Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06494150
Title Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Acronym NARETO
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.